The deal for the privately held U.K.-based biotechnology agency will assist bolster Novartis’s oncology capabilities.
Source link
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Related Posts
Salesforce (CRM) Q2 earnings report 2026
Marc Benioff, co-founder and CEO of Salesforce, sits for an interview in San Francisco on April 25, 2025. David Paul…
A ‘Blood Moon’ Total Lunar Eclipse Sets Up A Solar Eclipse
Topline September’s full moon lit up the night sky across the world overnight on Sept. 7, 2025, with half the…
Prediction Markets Let You Bet on Whether a Wildfire Will Burn Down Your Town
Sylvie Andrews and her associate didn’t simply lose the brand new home they’d helped construct when the Eaton Fireplace ripped…